Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology|April 2, 2005
Vesicular glutamate transporter-1 colocalizes with endogenous opioid peptides in axon terminals of the rat locus coeruleusJeffrey Barr, Elisabeth J Van BockstaeleBrain Research|September 11, 2007
Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleusMaria Waselus, Elisabeth J Van BockstaeleThe European Journal of Neuroscience|March 4, 2020
The role of catecholamines in modulating responses to stress: Sex-specific patterns, implications, and therapeutic potential for post-traumatic stress disorder and opiate withdrawalJennifer A Ross, Elisabeth J Van BockstaeleFrontiers in Psychiatry|February 15, 2021
The Locus Coeruleus- Norepinephrine System in Stress and Arousal: Unraveling Historical, Current, and Future PerspectivesJennifer A Ross, Elisabeth J Van BockstaeleNeuroscience Letters|June 23, 2011
Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversionAna Franky Carvalho, Elisabeth J Van BockstaeleProgress in Neuro-Psychopharmacology & Biological Psychiatry|February 3, 2012
Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disordersAna Franky Carvalho, Elisabeth J Van BockstaeleAnatomical Record (Hoboken, N.J. : 2007)|February 28, 2009
Mu-opioid receptor redistribution in the locus coeruleus upon precipitation of withdrawal in opiate-dependent ratsJillian L Scavone, Elisabeth J Van BockstaeleAdvances in Pharmacology (San Diego, Calif.)|September 24, 2013
Neuropeptide regulation of the locus coeruleus and opiate-induced plasticity of stress responsesElisabeth J Van Bockstaele, Rita J ValentinoJournal of Addictive Diseases|June 21, 2006
Antagonist treatment of opioid withdrawal translational low dose approachPaolo Mannelli, Edward Gottheil, Elisabeth J Van BockstaeleExpert Opinion on Drug Discovery|December 10, 2014
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric diseaseRyan Wyrofsky, Paul McGonigle, Elisabeth J Van BockstaelePageof 9